INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,655 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$110K
500 sh
Mar 5, 2026Mar 6, 2026
Page 1165 of 1742
← PrevNext →
traded Mar 5, 2026
+1d
SEC Form 4

Evidence

8
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$64K
300 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

6
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Grant or award
A—
110.0K sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

5
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$156K
722 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

5
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$216K
1,007 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

5
AJ
Aguila JavierSee Remarks
HHyatt Hotels Corp
Tax withholding
F$39K
239 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

5
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$194K
900 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

5
MG
Martell Jorge GarciaChief Financial Officer
OSPNOneSpan Inc.
Option exercise
M—
3,055 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

5
BE
Bertels Mark E.EVP - Risk Management Services
CRVLCORVEL CORP
Grant or award
A—
6,000 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

5
SE
Storey Lisa EChief Legal Officer
EVCMEverCommerce Inc.
Tax withholding
F$19K
1,577 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

5
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Tax withholding
F$145K
12.0K sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

5
FA
Flees Lori AnnDirector, President & CEO
VVVVALVOLINE INC
Grant or award
A$974
27 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

5
MG
Martell Jorge GarciaChief Financial Officer
OSPNOneSpan Inc.
Tax withholding
F$9,681
889 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

5
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$45K
200 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

5
JR
Jain RachitEVP & CFO
SDGRSchrodinger, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
1,631 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

5
MG
Martell Jorge GarciaChief Financial Officer
OSPNOneSpan Inc.
Option exercise
M—
3,055 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

3
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M—
5,000 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

3
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
10.3K sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

1
FD
Feierstein Matthew DavidPresident
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$61K
5,000 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

1
FD
Feierstein Matthew DavidPresident
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$120K
10.0K sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

1
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$166K
803 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

1
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$105K
496 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

0
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$63K
10.3K sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

0
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M—
1,607 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

0
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M—
466 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

0
FD
Feierstein Matthew DavidPresident
EVCMEverCommerce Inc.
Tax withholding · 10b5-1 plan
F$53K
4,352 sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

0
MA
Mitchell AndreaDirector
DAVEDave Inc./DE
Open-market sale · 10b5-1 plan
SELL$41K
200 sh
Mar 6, 2026Mar 6, 2026
traded Mar 6, 2026
+0dSEC Form 4

Evidence

0
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M$38K
466 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

0
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M$94K
1,607 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC Form 4

Evidence

0
RJ
Riley JanelChief Accounting Officer
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M—
23.3K sh
Mar 5, 2026Mar 6, 2026
traded Mar 5, 2026
+1dSEC Form 4

Evidence

46
PM
Paravasthu MukundChief Operating Officer
NVCRNovoCure Ltd
Open-market sale
SELL$596K
43.2K sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC Form 4

Evidence

41
GD
Gabbay DanielEVP, Chief Financial Officer
HRHealthcare Realty Trust Inc
Open-market purchase
BUY$187
10 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

40
KJ
Kroll Lara JSVP & Chief Accounting Officer
CHRDChord Energy Corp
Open-market sale
SELL$568K
5,000 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

40
QA
Quigley AdamChief Financial Officer
SNSharkNinja, Inc.
Open-market sale
SELL$300K
2,620 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

39
AP
Aiyar PriyaChief Legal Officer
WBDWarner Bros. Discovery, Inc.
Open-market sale
SELL$6.31M
223.5K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

39
BC
Brackmann ChristophChief Financial Officer
NVCRNovoCure Ltd
Open-market sale
SELL$85K
6,412 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

39
WX
Wan XinChief Technology Officer
GCTGigaCloud Technology Inc
Open-market sale
SELL$4.34M
100.0K sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC Form 4

Evidence

39
SJ
Shen Zheng JohnDirector
VICRVICOR CORP
Open-market sale
SELL$250K
1,217 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

39
PM
Paravasthu MukundChief Operating Officer
NVCRNovoCure Ltd
Open-market sale
SELL$72K
5,377 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

39
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market sale
SELL$1.25M
13.0K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence